US Patent Issued to Medtronic Ireland Manufacturing UnLtd. on July 29 for "Selection of hypertensive patients for treatment with renal denervation" (Florida, Minnesota, California, New York Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,369,982, issued on July 29, was assigned to Medtronic Ireland Manufacturing UnLtd. Co. (Dublin).

"Selection of hypertensive patients for treatment with renal denervation" was invented by Sandeep Brar (Dublin, Calif.), Martin Fahy (Brooklyn, N.Y.), Vanessa Debruin (Lake Elmo, Minn.) and Colleen Gilbert (Tallahassee, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, systems, devices, assemblies and apparatuses for treatment of hypertension in a patient using renal denervation. The therapeutic assembly includes an energy delivery element. The energy delivery element is configured to provide renal denervation energy to a nerve within a blood vess...